English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
As Health Systems Struggle With Nursing Shortages, CGFNS International Sees a Sharp Rise in Nurses Seeking to Migrate to the U.S.
Dec 06, 2023 22:00 HKT
透云生物引领餐饮界新「潮流」 莱茵衣藻获逾百家知名餐饮品牌及米芝莲餐厅入馔
Dec 05, 2023 10:00 HKT
透雲生物引領餐飲界新「潮流」 萊茵衣藻獲逾百家知名餐飲品牌及米芝蓮餐廳入饌
Dec 05, 2023 09:59 HKT
Acrometa Posts Record Revenue of S$69.5 Million for FY2023, Continues to Pursue New Opportunities in Co-Working Lab Space Business
Nov 29, 2023 20:00 HKT
Nano-sized probes reveal how cellular structure responds to pressure
Nov 21, 2023 07:00 HKT
Acrometa Subsidiary Signs Two MOUs to Develop Co-Working Laboratory Space Business in China
Nov 17, 2023 21:00 HKT
The Largest Biotech City in Europe Will Soon Be Built, With an Investment Amounting to 7 Billion Euros
Nov 17, 2023 09:30 HKT
Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
Nov 15, 2023 20:00 HKT
ZAGENO Secures Esteemed Placement in the 2023 ProcureTech100 Elite
Nov 15, 2023 20:00 HKT
Indonesia's ITS Launches 7 MedTech Devices Based on Various Integrated Technologies
Nov 09, 2023 21:00 HKT
BioMed X Launches a New Call for Application in Autoimmune Disease Research
Nov 07, 2023 19:00 HKT
Acrometa Group Signs MOU for Sand Concession, Opening New Business Opportunities in the Region
Nov 06, 2023 21:00 HKT
DC Healthcare Unveils Innovative Skincare Range 'newB' Under Subsidiary Ten Doctors Sdn Bhd
Nov 01, 2023 19:00 HKT
BioMed X and AbbVie Start New Research Project in the USA
Nov 01, 2023 07:00 HKT
Acrometa to Focus on Laboratory Construction and Co-Working Laboratory Space Business
Oct 31, 2023 21:00 HKT
EW Healthcare Partners Acquires Stake in Boiron Group, a Leader in Natural Medicine
Oct 27, 2023 21:00 HKT
四环医药(0460.HK)旗下轩竹生物自主研发吡罗西尼单药II期试验入选2023 ESMO 为晚期HR+/HER2-乳腺癌患者提供了新思路
Oct 24, 2023 10:50 HKT
四環醫藥(0460.HK):旗下軒竹生物自主研發吡羅西尼單藥II期試驗入選2023 ESMO 重磅臨床試驗結果再次登上國際舞台
Oct 24, 2023 10:49 HKT
아방스 클리니컬, 45개의 한국 생명 공학 기업 초청해 한국과 호주에서 미국으로 이어지는 글로벌레디 신약 개발 경로에 대한 설명회 개최
Oct 19, 2023 18:00 HKT
Avance Clinical Invited to Brief 45 Korean Biotechs on Their GlobalReady Drug Development Pathway from Korea and Australia to the US
Oct 19, 2023 09:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: